Kharas, M. G., Janes, M. R., Scarfone, V. M., Lilly, M. B., Knight, Z. A., Shokat, K. M., & Fruman, D. A. (2008). Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL(+) leukemia cells. American Society for Clinical Investigation.

Kharas, Michael G., Matthew R. Janes, Vanessa M. Scarfone, Michael B. Lilly, Zachary A. Knight, Kevan M. Shokat, and David A. Fruman. Ablation of PI3K Blocks BCR-ABL Leukemogenesis in Mice, and a Dual PI3K/mTOR Inhibitor Prevents Expansion of Human BCR-ABL(+) Leukemia Cells. American Society for Clinical Investigation, 2008.

Kharas, Michael G., et al. Ablation of PI3K Blocks BCR-ABL Leukemogenesis in Mice, and a Dual PI3K/mTOR Inhibitor Prevents Expansion of Human BCR-ABL(+) Leukemia Cells. American Society for Clinical Investigation, 2008.